Skip Navigation


ToxSci Advance Access originally published online on October 12, 2005
Toxicological Sciences 2006 89(1):173-187; doi:10.1093/toxsci/kfj009
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
89/1/173    most recent
kfj009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sonneveld, E.
Right arrow Articles by van der Burg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonneveld, E.
Right arrow Articles by van der Burg, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comparison of In Vitro and In Vivo Screening Models for Androgenic and Estrogenic Activities

Edwin Sonneveld*,1, Jacoba A. C. Riteco*, Hendrina J. Jansen*, Bart Pieterse*, Abraham Brouwer*,{dagger}, Willem G. Schoonen{ddagger} and Bart van der Burg*

* BioDetection Systems B.V., Amsterdam, The Netherlands; {dagger} Institute for Environmental Studies, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and {ddagger} Department of Pharmacology, NV Organon, Oss, The Netherlands

Received August 25, 2005; accepted September 27, 2005

Identification of nuclear receptor–mediated endocrine activities is important in a variety of fields, ranging from pharmacological and clinical screening, to food and feed safety, toxicological monitoring, and risk assessment. Traditionally animal studies such as the Hershberger and Allen-Doisy tests are used for the assessment of androgenic and estrogenic potencies, respectively. To allow fast analysis of the activities of new chemicals, food additives, and pharmaceutical compounds, high-throughput screening strategies have been developed. Here, a panel of mainly steroidal compounds, screened in different in vitro assays, was compared with two human U2-OS cell line–based CALUX® (Chemically Activated LUciferase eXpression) reporter gene assays for androgens (AR CALUX) and estrogens (ER{alpha} CALUX). Correlations found between the data of these two CALUX reporter gene assays and data obtained with other in vitro screening assays measuring receptor binding or reporter gene activation (CHO cell line–based) were good (correlation coefficients (r2) between 0.54 and 0.76; p < 0.0001). Good correlations were also found between the in vitro and in vivo data (correlation coefficient r2 = 0.46 for the AR CALUX vs. Hershberger assay and r2 = 0.87 for the ER{alpha} CALUX vs. Allen-Doisy assay). The variations in the results obtained with the reporter gene assays (CALUX vs. CHO cell line based) were relatively small, showing the robustness of these types of assays. Using hierarchical clustering, bioactivity relationships between compounds but also relationships between various bioassays were determined. The in vitro assays were found to be good predictors of in vivo androgenic or estrogenic activity of a range of compounds, allowing prescreen and/or possible reduction of animal studies.

Key Words: androgen; estrogen; CALUX; bioassay; Hershberger; Allen-Doisy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Behav EcolHome page
S. A. Kingma, J. Komdeur, O. Vedder, N. von Engelhardt, P. Korsten, and T. G.G. Groothuis
Manipulation of male attractiveness induces rapid changes in avian maternal yolk androgen deposition
Behav. Ecol., January 1, 2009; 20(1): 172 - 179.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. M. Sotoca Covaleda, H. van den Berg, J. Vervoort, P. van der Saag, A. Strom, J.-A. Gustafsson, I. Rietjens, and A. J. Murk
Influence of Cellular ER{alpha}/ER{beta} Ratio on the ER{alpha}-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
Toxicol. Sci., October 1, 2008; 105(2): 303 - 311.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
Ton. G.G Groothuis and H. Schwabl
Hormone-mediated maternal effects in birds: mechanisms matter but what do we know of them?
Phil Trans R Soc B, May 12, 2008; 363(1497): 1647 - 1661.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Roy, M. Alevizaki, and I. Huhtaniemi
In vitro bioassays for androgens and their diagnostic applications
Hum. Reprod. Update, January 1, 2008; 14(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
M. L. Eldridge, J. Sanseverino, A. C. Layton, J. P. Easter, T. W. Schultz, and G. S. Sayler
Saccharomyces cerevisiae BLYAS, a New Bioluminescent Bioreporter for Detection of Androgenic Compounds
Appl. Envir. Microbiol., October 1, 2007; 73(19): 6012 - 6018.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.